Furthermore, the phosphorylation of USP14 (S241) was substantially reduced in NiPT-treated CML cells, also indicative of suppression of the DUB activity of USP14 by NiPT treatment (Fig. 3d) [36]. The gene discussed is USP14; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.